)
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
The company's stock gained close to one per cent on BSE on Wednesday
'Positive consumer sentiment' leads to best number for that month, says SIAM
Nexon received a score of 32.22 out of 34 points for adult occupant protection and 44.52 out of 49 points for child occupant protection
Tata Motors slashes prices of Nexon, Tiago EVs by up to Rs 1.2 lakh
On the EV front, there is significant opportunity. At present, only 30-40 percent of the EV supply chain is localised
The company is generating good response from the potential bidders as it is focusing primarily on products in surgical and post surgical as well as chronic care
The company's stock slid 14.04 per cent on the Bombay Stock Exchange (BSE) on Monday, ending the day's trade at Rs 1,130.3 apiece
Siddharth Mittal outlines the growth strategies and challenges ahead
The anti-obesity drugs' market had a sluggish growth till 2021, says Sheetal Sapale, vice-president, commercial, Pharmarack, a market research firm
Chopra said company grows at 16% compared to Indian pharma market growth of 8%
Hyundai Motor is exploring an initial public offering (IPO) of its Indian unit to raise around $3 bn (at a valuation of up to $30 bn), according to sources
Nilesh Gupta, MD, Lupin Limited said, "We delivered our highest quarterly sales to date, crossed the Rs 5,000 crore mark for the first time, driven by strong growth across geographies."
Rajasthan, Gujarat, and Kerala see more users
The Insurance Regulatory and Development Authority of India has also asked companies to modify products that contain limitations for Ayush treatments and ensure compliance
The domestic formulation business has been the growth driver during the quarter, clocking a 14 per cent Y-o-Y growth to Rs 462 crore
In the Interim Budget speech on Thursday, Union Finance Minister Nirmala Sitharaman said "private investments are happening at scale"
Indian CDMOs are focusing on big biotech clients, and going forward, they believe the funding issues will not last long
The company remains upbeat on all three auto businesses and expects to do better in Q4
PLI benefits would range from 13-18% of revenue for vehicles approved by the government for the scheme
Push to include cervical cancer vaccination in Universal Immunisation Programme and set up more medical colleges